ARTICLE | Company News
KS Biomedix, Babraham form joint venture
June 12, 2001 7:00 AM UTC
KS Biomedix (LSE:KSB) and Babraham Bioscience ( Cambridge, U.K.) formed Discerna, a 50-50 joint venture that will combine KSB's therapeutic targets with Babraham's ribosome display technology to devel...